title: Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
abstract: X-linked severe combined immunodeficiency syndrome (X-SCID) is a genetic disorder characterized by profound impairment of cell-mediated and humoral immunity. Affected children die of recurrent infections within 2 years of birth unless rescued by allogeneic transplantation from a suitable donor. Recently, the genetic defect responsible for X-linked SCID has been identified as a mutation in the gamma chain of the IL-2 receptor, a protein also shared by the IL-4 and IL-7 receptors and therefore now denoted the common gamma chain (gamma c). We report here the development of a high-titer amphotropic retroviral vector for transfer of gamma c. This vector was used to transfer a copy of the gamma c cDNA to murine 3T3 fibroblasts, CD34-enriched hematopoietic progenitor cells obtained from bone marrow and umbilical cord blood of normal donors, and to transplanted murine bone marrow progenitors. Murine 3T3 cells transduced by the retroviral vector were analyzed by Southern blot hybridization and Western transfer. Southern analysis confirmed the integration of unrearranged proviral DNA, and Western blot analysis demonstrated the expression of gamma c protein. CD34-enriched cells were infected with viral vectors bearing gamma c and grown in methylcellulose media. Individual colonies and pools of cells were analyzed 2 weeks later by polymerase chain reaction assay, which confirmed the proviral marking. The vector was also used to transfer a copy of the gamma c cDNA to murine bone marrow cells in a transplantation model. Infected marrow was transplanted into syngeneic Balb/c mice.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Hematology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD 20892, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Qazilbash
authors.forename: C E
authors.initials: CE
authors.lastname: Walsh
authors.forename: S M
authors.initials: SM
authors.lastname: Russell
authors.forename: M
authors.initials: M
authors.lastname: Noguchi
authors.forename: M M
authors.initials: MM
authors.lastname: Mann
authors.forename: W J
authors.initials: WJ
authors.lastname: Leonard
authors.forename: J M
authors.initials: JM
authors.lastname: Liu
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D015703:Antigens, CD / Q000235:genetics*; D001483:Base Sequence; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D018076:DNA, Complementary; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors; D006412:Hematopoietic Stem Cells; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D018123:Receptors, Interleukin / Q000235:genetics*; D015375:Receptors, Interleukin-2 / Q000235:genetics*; D020395:Receptors, Interleukin-7; D012190:Retroviridae / Q000235:genetics*; D016511:Severe Combined Immunodeficiency / Q000628:therapy*; D014170:Transformation, Genetic
chemical_list: D015703:Antigens, CD; D018076:DNA, Complementary; D018123:Receptors, Interleukin; D015375:Receptors, Interleukin-2; D020395:Receptors, Interleukin-7